Skip to content
← Full study record

NCT01842646 · MORE INFO

Limitations, agreements, and source contact

Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) · Source last updated 2021-06-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
jeffrey.lancet@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-1387
title
Dr. Jeffrey Lancet
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
jeffrey.lancet@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-1387
title
Dr. Jeffrey Lancet

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice